Josep Mercader
@josepmercader.bsky.social
86 followers 86 following 6 posts
Posts Media Videos Starter Packs
Reposted by Josep Mercader
finngen.bsky.social
We’re getting ready for an exciting week at #ASHG2025 in Boston! Come meet the FinnGen team at booth 147 - we’ll be sharing updates and showcasing new public resources and tools. Plus, don’t miss the various presentations featuring FinnGen results across the program!
www.finngen.fi/en/meet-finn...
Meet FinnGen at the ASHG 2025! | FinnGen
Results based on the FinnGen data are presented in almost 40 talks or posters during the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) in Boston, October 14-18. We also have a b...
www.finngen.fi
Reposted by Josep Mercader
pragskore.bsky.social
📃 We’re excited to share our latest work, now published in Nature Communications — a major update to the Genome Aggregation Database (gnomAD) that improves allele frequency resolution for two gnomAD-defined genetic ancestry groups using local ancestry inference (LAI).
Improved allele frequencies in gnomAD through local ancestry inference - Nature Communications
This study incorporates local ancestry into the Genome Aggregation Database (gnomAD) to improve allele frequency estimates for admixed populations, enhancing variant interpretation and enabling more accurate and equitable genomic research and clinical care.
www.nature.com
Reposted by Josep Mercader
gwascatalog.bsky.social
GWAS finds millions of variants — but what are the Predicted Effector Genes (PEGs)? Our Nature Genetics Perspective rdcu.be/eoqVk showed big inconsistencies.
At ASHG 2025, we’ll introduce a new standard to make PEG data FAIR.
🗓️ Ancillary Session: Oct 17 | 11:45 | Room 259A
📌Poster: Oct 16 | 2:30
Realizing the promise of genome-wide association studies for effector gene prediction
Nature Genetics - This Perspective argues that predicting effector genes for complex diseases is a key outcome of genetic association studies where standards are urgently needed to maximize...
rdcu.be
Reposted by Josep Mercader
medrxivpreprint.bsky.social
Exome-wide association study in 54,698 south Asians identifies novel type 2 diabetes associations with RNF19A, HNF4A, and dissects role of coding variants in GP2 and CDKAL1 https://www.medrxiv.org/content/10.1101/2025.09.24.25336527v1
Reposted by Josep Mercader
jamesr-s.bsky.social
I’m excited to share the 2 newest Neonatal diabetes genes: RNU4ATAC and RNU6ATAC. These genes encode snRNA components of the minor spliceosome and biallelic variants in them cause monogenic autoimmune diabetes. If you are at #EASD, come to Matt Johnson’s talk Tuesday @4pm in Milan hall to hear more.
The minor spliceosome is a master immune regulator
Pathogenic variants in non-coding genes are emerging as critical contributors to human rare diseases. We identified 19 individuals with early-onset diabetes (diagnosed <5 years) and additional clinica...
www.medrxiv.org
Reposted by Josep Mercader
hakyim.bsky.social
I'm hiring a computational biologist interested in complex trait genetics using deep learning approaches. Reach out to me, if interested.
Reposted by Josep Mercader
egatkinson.bsky.social
Delighted to amplify my talented PhD student’s work! Check it out for a great way to streamline and harmonize Tractor analyses.
nirav-shah.bsky.social
🚨 New preprint! Traditional GWAS often exclude admixed individuals, missing ancestry-enriched genetic signals. We built Tractor Nextflow Workflow - a modular, scalable pipeline that automates phasing, LAI, and Tractor GWAS, alongside comprehensive documentation.
Preprint: doi.org/10.1101/2025...
Tractor Workflow Pipeline: A Scalable Nextflow Framework for Local Ancestry-Aware Genome-Wide Association Studies
The routine exclusion of admixed individuals from traditional Genome-Wide Association Studies (GWAS) due to concerns about spurious associations has hindered genetic analyses involving multiple ancest...
www.biorxiv.org
Reposted by Josep Mercader
sashagusevposts.bsky.social
I wrote about gene-gene interactions (epistasis) and the implications for heritability, trait definitions, natural selection, and therapeutic interventions. Biology is clearly full of causal interactions, so why don't we see them in the data? A 🧵:
Beneath the surface of the sum
When genetic interactions matter and when they don't
open.substack.com
josepmercader.bsky.social
We will soon make these PRSs weights publicly available via @pgscatalog.bsky.social‬ to support further evaluation of their clinical utility in diverse ancestries. Thanks to all the participants and cohorts in the Diabetes Polygenic RIsk Scores in Multiple ancestries (#D-PRISM) consortium!
josepmercader.bsky.social
Our PRSs outperform all previously published T2D PRS for any ancestry and can identify 2.5% with ~6-fold increased risk in AMR, EAS and EUR, and >3-fold risk in AFR and SAS, emphasizing the need of more genetic data from AFR and SAS. PRSs are also associated with increased risk of complications.
josepmercader.bsky.social
This global effort gathered data from 360K T2D and 1.8 M controls to develop a multi-ancestry T2D PRS that was validated in at least four cohorts from each of five ancestry groups (European-like (EUR), African/African American (AFR), Admixed American (AMR), South Asian (SAS) and East Asian (EAS)).
Reposted by Josep Mercader
jacquesml.bsky.social
New preprint out now! We show polygenic background shapes GCK-MODY clinical presentation. In >1,000 cases, higher polygenic risk increased the chance of exceeding diagnostic diabetes thresholds, highlighting how monogenic & polygenic factors jointly shape disease. #Genetics
medrxivpreprint.bsky.social
Polygenic Background Contributes to GCK-MODY Clinical Presentation and Glycaemic Variability https://www.medrxiv.org/content/10.1101/2025.08.04.25332935v1
Reposted by Josep Mercader
medrxivpreprint.bsky.social
Polygenic Background Contributes to GCK-MODY Clinical Presentation and Glycaemic Variability https://www.medrxiv.org/content/10.1101/2025.08.04.25332935v1
Reposted by Josep Mercader
stevestonedraws.bsky.social
At #ADA2025, Josep Mercader discussed how multi-ancestry PRS for T2DM offer better prediction—especially when overlaid with clinical risk factors.
@amdiabetesassn.bsky.social @josepmercader.bsky.social
#ADASciSessions #genomics #PRS #T2D #ancestryinresearch
Reposted by Josep Mercader
sashagusevposts.bsky.social
I wrote about how genetic risk works in the context of embryo selection and how people often think about it all wrong. A short 🧵:
What we talk about when we talk about risk
How embryo selection exploits our flawed intuitions about risk
open.substack.com
Reposted by Josep Mercader
Reposted by Josep Mercader
nmancuso.bsky.social
Super excited to see this out. What started as some math in a grant in 2020, to a student deciding to take this on in 2022, to published in 2025.

These things can take time and patience is key!